Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Group 1 (advanced or metastatic lung cancer):
- Adults aged 18 or older
- People who have been diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC), confirmed through a tissue sample (biopsy)
- People whose ability to carry out daily activities falls within an acceptable range as assessed by their doctor (confirm with trial site)
- People whose cancer has a specific genetic change — such as in the EGFR, ALK, ROS1, RET, MET, KRAS, BRAF, HER2, or NTRK genes — identified through standard clinical testing
- People whose doctor has planned for them to start a targeted cancer therapy (at any stage of treatment), including certain newer antibody-based treatments
- People for whom regular follow-up and cancer monitoring appointments are already planned at the enrolling site
- People who have given written consent to take part in the study
Group 2 (early-stage lung cancer before surgery):
- Adults aged 18 or older
- People who have been diagnosed with stage II or III non-small cell lung cancer (NSCLC) that a surgeon has assessed as operable, confirmed through a tissue sample
- People whose doctor has planned for them to receive immunotherapy treatment before surgery
- People who have given written consent to take part in the study
Who may not be able to join:
- People whose overall health is too unstable to reliably attend and complete the blood or tissue sampling required by the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Professor Sanjay Popat, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust
Phone: +44 2031865916
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The number of participants with paired samples of blood and viable tissue
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.